Literature DB >> 33669298

Plasma Xanthine Oxidoreductase Activity Is Associated with a High Risk of Cardiovascular Disease in a General Japanese Population.

Yuka Kotozaki1, Mamoru Satoh1,2, Kozo Tanno1,3, Hideki Ohmomo1, Ryo Otomo1, Fumitaka Tanaka1,4, Takahito Nasu1,2,5, Satoru Taguchi5, Hiroto Kikuchi5, Takamasa Kobayashi5, Atsushi Shimizu1,2, Kiyomi Sakata1,3, Jiro Hitomi1,6, Kenji Sobue7, Makoto Sasaki1,8.   

Abstract

The purpose of this study was to investigate the association between xanthine oxidoreductase (XOR) activity and a high risk of cardiovascular disease (CVD) in a general Japanese population. The Iwate Tohoku Medical Megabank Organization pooled individual participant data from a general population-based cohort study in Iwate prefecture. The cardiovascular risk was calculated using the Framingham Risk Score (FRS). A total of 1605 of the 1631 participants (98.4%) had detectable XOR activity. Multiple regression analysis demonstrated that XOR activity was independently associated with body mass index (β = 0.26, p < 0.001), diabetes (β = 0.09, p < 0.001), dyslipidemia (β = 0.08, p = 0.001), and uric acid (β = 0.13, p < 0.001). Multivariate analysis showed that the highest quartile of XOR activity was associated with a high risk for CVD (FRS ≥ 15) after adjustment for baseline characteristics (OR 2.93, 95% CI 1.16-7.40). The area under the receiver operating characteristic curves of the FRS with XOR activity was 0.81 (p = 0.008). XOR activity is associated with a high risk for CVD, suggesting that high XOR activity may indicate cardiovascular risk in a general Japanese population.

Entities:  

Keywords:  Framingham Risk Score; atherosclerosis; reactive oxygen species; the Iwate Tohoku Medical Megabank Organization; uric acid

Year:  2021        PMID: 33669298      PMCID: PMC7920066          DOI: 10.3390/ijerph18041894

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  28 in total

1.  Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian Type 2 diabetes patients.

Authors:  U R Kuppusamy; M Indran; P Rokiah
Journal:  Diabet Med       Date:  2005-10       Impact factor: 4.359

Review 2.  The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury.

Authors:  T Nishino
Journal:  J Biochem       Date:  1994-07       Impact factor: 3.387

3.  A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC/TQMS.

Authors:  Takayo Murase; Mai Nampei; Mitsuru Oka; Atsushi Miyachi; Takashi Nakamura
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-10-24       Impact factor: 3.205

4.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

Authors:  J S Yudkin; C D Stehouwer; J J Emeis; S W Coppack
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

5.  Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure.

Authors:  Yoichiro Otaki; Tetsu Watanabe; Daisuke Kinoshita; Miyuki Yokoyama; Tetsuya Takahashi; Taku Toshima; Takayuki Sugai; Takayo Murase; Takashi Nakamura; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Tetsuro Shishido; Takuya Miyamoto; Isao Kubota
Journal:  Int J Cardiol       Date:  2016-11-09       Impact factor: 4.164

Review 6.  Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.

Authors:  Ulrich Förstermann; Ning Xia; Huige Li
Journal:  Circ Res       Date:  2017-02-17       Impact factor: 17.367

Review 7.  Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme.

Authors:  Maria Giulia Battelli; Andrea Bolognesi; Letizia Polito
Journal:  Biochim Biophys Acta       Date:  2014-05-29

8.  Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population.

Authors:  Masato Furuhashi; Megumi Matsumoto; Marenao Tanaka; Norihito Moniwa; Takayo Murase; Takashi Nakamura; Hirofumi Ohnishi; Shigeyuki Saitoh; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Circ J       Date:  2018-04-10       Impact factor: 2.993

9.  Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients.

Authors:  Yuki Fujimura; Yohei Yamauchi; Takayo Murase; Takashi Nakamura; Shu-Ichi Fujita; Tomohiro Fujisaka; Takahide Ito; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

10.  Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.

Authors:  Ayumi Nakatani; Shinya Nakatani; Eiji Ishimura; Takayo Murase; Takashi Nakamura; Mari Sakura; Yu Tateishi; Akihiro Tsuda; Masafumi Kurajoh; Katsuhito Mori; Masanori Emoto; Masaaki Inaba
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

View more
  2 in total

1.  Uric acid, xanthine oxidase, and vascular damage: potential of xanthine oxidoreductase inhibitors to prevent cardiovascular diseases.

Authors:  Hiromitsu Sekizuka
Journal:  Hypertens Res       Date:  2022-03-17       Impact factor: 3.872

2.  Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study.

Authors:  Keisei Kosaki; Atsumu Yokota; Koichiro Tanahashi; Kanae Myoenzono; Jiyeon Park; Toru Yoshikawa; Yasuko Yoshida; Takayo Murase; Seigo Akari; Takashi Nakamura; Seiji Maeda
Journal:  J Clin Biochem Nutr       Date:  2022-04-12       Impact factor: 3.179

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.